Polyrizon European Patent Application Published for Nasal Drug Delivery

Polyrizon Ltd. announced that the European Patent Office (EPO) has completed technical preparations for the publication of its European patent application, EP 4751737, titled "Mucoadhesive Polymers for Nasal Drug Delivery." This patent application covers the company's proprietary Trap & Target™ (T&T) mucoadhesive polymer technology platform, designed to enhance nasal drug delivery by improving formulation retention and drug absorption. CEO Tomer Izraeli stated this is a significant step in strengthening Polyrizon's position in the growing nasal drug delivery market and expanding its intellectual property portfolio. The patent application will continue through the examination process, potentially providing intellectual property protection across multiple European markets if granted.